Most organisms, including bacteria, require iron. Bacteria encounter various types of environmental iron sources, including ferric and ferrous iron, iron-containing siderophores, heme, heme carrier proteins, and hemophores (10) . In most cases, bacterial iron needs are covered by tightly regulated iron/heme uptake systems encoded by genes clustered in operons expressed only under iron deficiency conditions (2) . In the presence of high intracellular iron concentrations, these operons are repressed by a common regulator, the iron-loaded Fur protein (3, 17) .
However, not all iron acquisition systems are simultaneously induced in response to iron limitation. Many systems are also positively regulated by the availability of a specific iron source (9, 33) . In gram-negative bacteria, iron/heme ligands are recognized by specific outer membrane proteins that play a key role in active transport and ligand-mediated positive regulation (13) . These receptors have similar overall structures, with a membrane-inserted ␤ barrel closed by an N-terminal plug region (15) . The activity of these receptors is dependent on the TonB-ExbB-ExbD inner membrane protein complex, with which they interact via a short conserved region, named the TonB box, near the receptor's N terminus (6) .
Ligand receptor binding, even in the absence of transport, is sufficient to induce transcription of the corresponding ligand uptake genes (12) . This response to the extracellular environment is mediated by extracytoplasmic function (ECF) sigma factors and membrane-bound anti-sigma factors (4, 5, 21) . Binding of the iron ligand to its cognate outer membrane receptor releases the anti-sigma factor-mediated inhibition of the ECF sigma factor, inducing transcription of the target operons (18) . The TonB-ExbB-ExbD complex is also required for transmembrane signaling. All the outer membrane receptors known to be regulated in this manner have a 50-to 100-amino-acid N-terminal regulatory extension beyond the TonB box; this extension is essential for sigma activation (32) .
The Serratia marcescens hemophore-dependent heme-acquisition system (Has) is subject to this type of regulation (31) . The Has system consists of a Fur-regulated operon encoding HasR, the hemophore-specific outer membrane receptor, HasA, the hemophore, and HasD and HasE, the specific inner membrane hemophore secretion proteins (16) . The final gene of the has operon, hasB, encodes a TonB homolog involved in heme uptake via the Has system (29) . Two genes immediately upstream of the has operon encode HasI, an ECF sigma factor, and HasS, an anti-sigma factor (31) .
The heme-loaded hemophore is a globular 19-kDa protein with H32 and Y75 double iron coordination. The H83 residue is an alternative ligand of heme iron (24) . The seven ␤ strands form an antiparallel ␤-sheet on one face of the protein, and the four ␣ helices are positioned on the other face (1).
The hemophore receptor, HasR, resembles other outer membrane receptors that are dependent on TonB for energy. It is predicted to have a similar three-dimensional structure, with a plug and a ␤ barrel (26) . HasR also functions as a heme receptor, taking up free and hemoglobin-bound heme, albeit less efficiently than it takes up hemophore-bound heme (16) . HasR contains two histidine residues (H189 and H603) that have been shown to be conserved in several heme receptors (8) and to be required for free and hemophore-bound heme uptake (F. Huché, N. Izadi-Pruneyre, A. Lecroisey, R. Gilli, C. Wandersman, and P. Delepelaire, unpublished data). HasR binds free heme with a K d around 1 M. It binds apo-and holo-hemophores at the same or overlapping sites with similar apparent K d values (5 nM) (24) . This interaction is mediated by two independent hemophore-binding regions, ␤ strands 51-60 and 95-105 (22) . The binding of heme or hemophore and the transfer of heme from the hemophore to the receptor are energy independent. In contrast, heme transport and the release of heme-free hemophore require energy, with hemophore release demanding the most energy (23) .
The has operon is induced by a heme-loaded hemophore (holo-HasA). This signaling process is dependent both on HasR and on HasI and HasS (31) and has been fully reconstituted in Escherichia coli (7) . Neither heme nor apo-HasA can induce hasR expression, raising questions about the nature of the induction stimulus (7) .
We used a collection of HasR and HasA mutants and showed that induction may result from the concomitant addition of two molecules that do not interact directly, heme and a mutant hemophore that does not bind heme. The apo-hemophore region required for induction is a five-amino-acid region located between positions 50 and 55 in one of the two HasRbinding regions of the hemophore.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 .
Media and growth conditions. Bovine hemoglobin, ␦-aminolevulinic acid, and 2,2Јdipyridyl were obtained from Sigma. The hemoglobin concentration was calculated based on the levels of heme monomer. Hemoglobin and ␦-aminolevulinic acid solutions were filter sterilized by using filters with 0.45-m pores. Bacteria were grown aerobically at 37°C in LB rich medium or in M63B1 or M9 minimal medium (28) supplemented with 0.4% glucose or 0.4% glycerol as a source of carbon. When required, ammonium iron(III) citrate was added to a final concentration of 5 M. The iron chelator 2,2Јdipyridyl was used at a final concentration of 0.2 mM, and ␦-aminolevulinic acid was used at a final concentration of 20 g · ml
Ϫ1
. Antibiotics were added to the following final concentrations: ampicillin, 50 g · ml
; spectinomycin, 100 g · ml
; chloramphenicol, 20 g · ml
; and kanamycin, 25 g · ml
. Solid media contained 1.5% Difco agar. Genetic techniques. Cells were transformed by the calcium chloride method (27) or by electroporation (14) . DNA manipulation and molecular cloning. Large-scale plasmid DNA preparations were obtained with a QIAfilter plasmid midi kit (QIAGEN Inc.), used according to the manufacturer's instructions. Small-scale plasmid DNA preparations were obtained with a QIAprep spin miniprep kit (QIAGEN Inc.), used according to the manufacturer's instructions. Restriction, modification, and ligation were carried out according to the recommendations of the kit manufacturers. Nucleotide sequencing was performed by Genome Express.
Site-directed mutagenesis. Site-directed mutagenesis was carried out with a Stratagene QuickChange XL site-directed mutagenesis kit (catalog no. 200516) and was verified by sequencing. Mutants T49, T50, T56, G95P, H32AY75AH83AS51P, and H32AY75AH83AG95V were generated in pAM238-hasA by using the primers described in Table 2 . The pentapeptide insertions generated in all the HasA mutants used are described in Table 3 .
Plasmid construction. We constructed pAMrbshasISRH1H2 by replacing the mutant copy of the hasR gene (D1, a large part of the hasR sequence deleted) in pAMrbshasISRD1 with the hasR gene of interest (H1H2). The donor plasmid pBAD24hasRH1H2 was cut with FseI and KpnI, which cleaved the ends of the hasR gene. The FseI-KpnI fragment containing hasRH1H2 was then purified and ligated with the recipient plasmid, pAMrbshasISRD1, which was previously digested with FseI and KpnI. The resulting construct was used to transform cells, and clones containing the pAM recombinant plasmid (pAMhasISRH1H2) were selected on plates containing spectinomycin and screened in digestion experiments.
Electrophoresis and immunological techniques. Proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by Coomassie blue staining. Dot blot HasA binding assays were performed with cultures of C600(pBAD24) and C600(pFR2hasR), as previously described (24) . Briefly, aliquots (50 l; approximately 10 7 CFU) of washed cell pellets were applied to nitrocellulose filters. Dot blotting with serial dilutions of wild-type or mutant apo-HasA proteins or no HasA was performed as described by Letoffe et al. (25) .
Preparation of apo-HasA proteins and loading with heme. Apo-HasA proteins were obtained from the culture supernatant of strain POP3(pACYC184-hasDE, pAM 238-hasA) grown at 30°C in M9 glycerol medium supplemented with 5 M ammonium iron(III) citrate. The supernatant was collected and concentrated by precipitation with 65% ammonium sulfate. A 5-to 10-ml aliquot of the sample was then extensively dialyzed in a cassette (Slide-A-Lyser dialysis cassette [extra strength] from Pierce) against 1 liter of TN buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl) containing protease inhibitors (Complete EDTA-free protease inhibitor cocktail tablets from Roche). Aliquots of the dialyzed preparation were frozen and stored at Ϫ20°C. The heme content of the protein, as determined from absorbance at the Soret band wavelength, was less than 0.5% in all cases. The purity of protein preparations was more than 99%, as shown by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Apo-HasA was loaded with heme by mixing 1 ml of 5 ϫ 10 Ϫ6 M apo-HasA in TN buffer with 1 ml of 4.5 ϫ 10 Ϫ6 M heme in TN buffer and incubating the preparation for 15 min at room temperature. Holo-HasA heme loading was determined based on Soret band intensity.
␤-Galactosidase assay. ␤-Galactosidase was assayed as described by Pardee et al. (30) .
RESULTS
Heme transfer from HasA to HasR is required for induction of the has signaling cascade. (i) Study of a HasA mutant affected in heme release. One mutant from our pentapeptide insertion mutant collection, HasA 76T, had the following properties: pentapeptide insertion between residues 76 and 77 (Fig. 1 M), and binding to the receptor with an affinity similar to that of the wild-type protein (22) . These properties and the results of a circular dichroism analysis suggested that the mutant and wildtype proteins had similar conformations (data not shown). However, the mutant was unable to supply heme to cells expressing H32AY75AH83AG95V  5Ј-ATTCCCTGTCCTTCGTCGACGGTTGAGCGGT-3Ј  5Ј-ACCGCTCAAACCGTCGACGAAGGACAGGGAATC-3Ј  H32AY75AH83AS5P  5Ј-TTCTATGGCGGCAGCCTGCCCGGTAGTCAGTA  TGCC-3Ј   5Ј-ATGGCATACTGACTACCGGGCAGGCTGCCGCC  ATAG-3Ј  T50  5Ј-TTCTATGGCGGCAGCCTGGGGTACCCCAGTATGT  CCGGTAGTCAGTATGCC-3Ј   5Ј-ATACTGACTACCGGACATACTGGGGTACCCCAGGC  TGCCGCCATAGAAGCC-3Ј  T56  5Ј-TCCGGTAGTCAGTATGCCGGGTACCCCACTATGA  TCAGTAGCACGGCAAACC-3Ј   5Ј-TTTGCCGTGCTACTGATCATACTGGGGTACCCGGC  ATACTGACTACCGG-3Ј  T49  5Ј-TTCTATGGCGGCAGCGGGTACCCCAGTATGCTGT  CCGGTAGTCAGTATGCC-3Ј   5Ј-ATACTGACTACCGGACAGCATACTGGGGTACCCGC  TGCCGCCATAGAAGCC-3Ј  G95P 5Ј-ATTCCCTGTCCTTCCCCGACGGTTTGAGCGGTG-3Ј 5Ј-ACCGCTCAAACCGTCGGGGAAGGACAGGGAATC-3Ј 
... D 181 -RGTPD-S 182
a The numbers indicate the position of the last amino acid preceding the pentapeptide insertion. Mutants obtained with the Tn4430 transposon are indicated by "in vivo" (22) ; "in vitro" indicates the mutants obtained by site-directed mutagenesis leading to a pentapeptide insertion.
HasR. Also, it displayed no heme transfer from holo-HasA 76T to apo-HasR "in vitro" (Huché, unpublished data). The mutation therefore seemed to involve heme release. All our studies of hasR-lacZ induction were carried out in E. coli strain POP3BF1 (POP3 fur::Cm att::hasR-lacZ) and its derivatives. Addition of holo-HasA 76T to strain POP3BF1(pAMrbshasISR) in M63 glucose medium did not induce expression of the hasR-lacZ fusion, whereas a holo-HasA wild-type hemophore induced expression of the fusion by a factor of about 15, as previously reported (7) (Fig. 2) . The heme-loading status of holo-HasA 76T was monitored during the incubation; unlike wild-type holo-HasA, the mutant protein continued to display 100% heme loading throughout the experiment (data not shown). HasA 76T had a lower affinity for heme than the wild-type protein, and the insertion affected the heme pocket. We therefore evaluated the induction activities of heme pocket mutants with affinities for heme of 10 Ϫ11 M (wildtype HasA and HasAH32A), 5 ϫ 10 Ϫ9 M (HasAY75A), and 10 Ϫ7 M (HasAH32AY75A) (24) . These mutants supply heme to HasR-expressing cells (24) . Mutant proteins loaded with heme were added to strain POP3BF1(pAMrbshasISR). All the heme pocket mutants tested induced the hasR-lacZ fusion about 30% less efficiently than the wild type, implying that the heme pocket per se is not involved in hasR induction (Fig. 2) .
(ii) HasR mutant study. We used a HasR mutant unable to use free or hemophore-bound heme. This mutant carries the mutations H189A and H603A (H1H2) and has no affinity for heme (Huché et al., unpublished). E. coli strain POP3BF1 was transformed with pAMrbshasISR (a plasmid containing wildtype hasR) or pAMrbshasISRH1H2 (encoding the HasR mutant protein). Production of the mutant protein was assessed by immunodetection with anti-HasR antibodies (data not shown). Similar amounts of the mutant and wild-type proteins were produced. The presence of the mutant at the cell surface and its reactivity with HasA were confirmed by dot blot assays with whole cells (data not shown). Strains POP3BF1(pAMrbshasISR) and POP3BF1(pAMrbshasISRH1H2) were grown in M63 glucose medium. They displayed ␤-galactosidase activity at subinduction levels. Holo-HasA increased hasR-lacZ expression by a factor of about 15 with the wild-type HasR receptor (Fig. 3) , as previously reported (7) . In contrast, the hasR-lacZ fusion was not induced following the addition of holo-HasA to cells producing HasRH1H2. Heme release from the hemophore was measured by determining the decrease in the cell culture supernatant holo-HasA Soret band intensity during the course of the induction experiment. Holo-hemophore incubated with the strain expressing the wild-type receptor was entirely unloaded, but holo-hemophore incubated with the strain expressing the mutant receptor displayed 100% loading throughout the experiment (data not shown).
This set of experiments with a HasA mutant unable to deliver heme and a HasR mutant unable to accept heme showed that holo-hemophore binding to HasR is not sufficient for induction; heme must reach the receptor for initiation of the has signaling cascade. However, heme alone is not sufficient for induction, suggesting that all or part of the HasA protein is also required for induction. We therefore tried to identify the hemophore regions required for hasR induction.
Identification of hemophore regions required for hasR induction. The interaction between HasA and HasR involves two HasA regions, a region between positions 51 and 60 and a region between positions 95 and 105. Single mutants S51P and G95V both bound HasR with high affinity, whereas the double mutant had no measurable affinity. All these mutants bound heme with high affinity and had the same overall structure as the wild type (22) .
We assessed the ability of the two previously described single mutants, S51P and G95V (22) , to induce hasR expression. Holo-HasA S51P and holo-HasA G95V were added to the test strain POP3BF1(pAMrbshasISR). Addition of holo-HasA G95V induced expression of the hasR-lacZ fusion about sevenfold. Holo-HasA S51P induced hasR-lacZ expression by a factor of two (Fig. 4A ). Other proteins with single changes in the two HasA binding regions were also tested, and holo-HasA S51A (not affected in HasA binding to HasR) fully induced the hasR-lacZ fusion (data not shown). Holo-HasA G95P induced the hasR-lacZ fusion to an extent similar to the extent observed with holo-HasA G95V (Fig. 4A) . Thus, the binding region lying between residues 95 and 105 can be deformed by a proline without significantly changing the HasA induction properties.
Two other mutants from the laboratory collection with pentapeptide insertions near residues 95 and 105 (Table 3) , HasAT99 and HasAT107, (22) , were tested for hasR induction. Both of these mutants induced the hasR-lacZ fusion to an extent similar to the extent observed with holo-HasA G95V (Fig. 4A) . The binding region of HasA between residues 51 and 60 is therefore clearly more important for induction than the binding region between residues 95 and 105 is.
Other HasA mutants carrying pentapeptide insertions at various positions in the HasA protein outside the two binding regions (positions 51 to 60 and 95 to 107) were also loaded with heme and tested. All of these mutants induced hasR to an extent similar to the extent observed with wild-type holo-HasA (Fig. 4B) , indicating the absence of significant involvement of any other HasA region in the initiation of signal transduction.
Scanning the 51-60 binding region for induction properties with pentapeptide insertion mutants. The failure of the HasA S51P mutant to induce hasR-lacZ suggested that the region between residues 51 and 60 in HasA is important for the initiation of has signaling.
We studied a collection of mutants (22) obtained by insertion of a pentapeptide into this region (see Materials and Methods) for precise identification of the residues important for holo-HasA-dependent hasR-lacZ induction. These mutant proteins were loaded with heme and tested for hasR-lacZ induction in the test strain. Little or no induction of the hasRlacZ fusion was observed with holo-HasA T50, holo-HasA T53, and holo-HasA T55. In contrast, holo-HasA T46, holoHasA T49, holo-HasA T56, holo-HasA T58, and holo-HasA T59 all strongly induced expression of the hasR-lacZ fusion (Fig. 5) . Holo-HasA T46 and holo-HasA T49 induced hasRlacZ expression to an extent similar to the extent observed with the wild type, indicating that the region upstream of residue 50 is not required for hasR induction. Pentapeptide scanning analysis therefore implicated residues 50 to 55 of the 51-60 ␤-strand in the initiation of has signaling.
Noninteracting heme and HasA are able to initiate the has signaling cascade. Both heme delivery and residues 50 to 55 of the 51-60 binding region of HasA were required for hasR-lacZ induction. We investigated whether these two induction factors could act separately by determining whether supplying free heme with HasA led to hasR induction. To prevent heme binding to HasA, a HasA H32AY75AH83A triple mutant unable to bind heme was used. Addition of HasA H32AY75AH83A or heme alone had no effect on hasR-lacZ expression in our test strain (Fig. 6) . Full hasR-lacZ expression, as observed with wild-type holoHasA, was induced in the presence of both heme and HasA H32AY75AH83A. The has signaling cascade may therefore be initiated in two ways: by holo-HasA and heme transfer to HasR or by concomitant addition of heme and the mutant hemophore unable to interact with heme. Heme binds to HasR on cells loaded with HasA H32AY75AH83A, inducing hasR-lacZ.
HasA H32AY75AH83A has been used to study heme uptake via HasR (23) . HasA H32AY75AH83A does not bind heme and blocks free heme uptake (23) . We compared the abilities of the wild-type and H32AY75AH83A hemophores to block heme uptake in the POP3 hasR-lacZ hemA(pAMrbshasISR) strain and its fur derivative. The H32AY75AH83A hemophore blocked heme uptake in both POP3 hasR-lacZ hemA(pAMrbshasISR) and its fur derivative. The H32AY75AH83A hemophore can therefore induce hasR expression while blocking heme uptake; heme transport is not required for hasR induction. Like HasA H32AY75AH83A, HasA 76T blocks heme transport. However, unlike HasA H32AY75AH83A, HasA 76T does not induce the hasR-lacZ fusion in the presence of heme.
HasA regions involved in induction in the presence of separately provided heme and hemophore. We introduced S51P and G95V mutations separately into HasA H32AY75AH83A to investigate the involvement of HasA binding regions 51-60 and 95-105 in the induction of has signaling in the presence of noninteracting heme and hemophore. The HasA quadruple mutants H32AY75AH83AS51P and H32AY75AH83AG95V were tested for hasR-lacZ induction (Fig. 6 ). Neither 10 Ϫ5 M heme nor 10 Ϫ7 M apo quadruple mutant supplied separately induced hasR. Concomitant addition of HasA H32AY75AH 83AG95V and heme induced hasR by a factor of five, whereas concomitant addition of HasA H32AY75AH83AS51P and heme did not induce hasR expression. In both cases, the amounts of the mutant proteins were similar to the amounts of the wild-type hemophore in controls at the end of the incubation period, as shown by immunodetection (data not shown). The quadruple mutant HasA H32AY75AH83AS51P interacted normally with HasR, as shown by dot blotting (data not shown). Thus, residue 51 is also required for hasR induction in the absence of an interaction between heme and the hemophore. The same region (region 50-55) of HasA is probably required for induction by holoHasA and for induction by noninteracting, separately supplied heme and hemophore.
DISCUSSION
Expression of the has operon of S. marcescens, which allows heme acquisition, is positively regulated by a transmembrane signaling cascade. This cascade is initiated by the binding of heme-loaded hemophore to HasR, its cognate receptor, which leads to specific sigma factor activation. HasR has a number of ligands, heme, apo-hemophore, and holo-hemophore, but only holo-hemophore initiates the signaling cascade. This raises questions concerning the nature of the inducing stimulus. This stimulus may be a particular holo-HasA conformation. Indeed, the three-dimensional structures of holo-HasA and apo-HasA indicate that heme binding to HasA substantially modifies the conformation of the heme pocket, without changing the ␣-␤ fold of the protein (1) (PDB accession number PDB ID 1YBJ). Alternatively, induction may result from the extraction of heme from HasA, heme landing on HasR, or empty hemophore recycling. 
